Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nektar Therapeutics
(NQ:
NKTR
)
1.350
+0.140 (+11.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,032,037
Open
1.220
Bid (Size)
1.240 (3)
Ask (Size)
1.350 (1)
Prev. Close
1.210
Today's Range
1.210 - 1.350
52wk Range
0.4127 - 1.928
Shares Outstanding
183,801,441
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NKTR Stock Earnings: Nektar Therapeutics Misses EPS, Beats Revenue for Q2 2024
August 08, 2024
NKTR stock results show that Nektar Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024
May 09, 2024
NKTR stock results show that Nektar Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
+126.97%
+126.97%
1 Month
-1.46%
-1.46%
3 Month
-10.00%
-10.00%
6 Month
+101.49%
+101.49%
1 Year
+111.27%
+111.27%
More News
Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 30, 2024
Via
Benzinga
Sweet Nektar?
April 22, 2024
Via
Talk Markets
Nektar Therapeutics Earnings Preview
March 01, 2024
Via
Benzinga
Recap: Nektar Therapeutics Q3 Earnings
November 07, 2023
Via
Benzinga
A Preview Of Nektar Therapeutics's Earnings
November 06, 2023
Via
Benzinga
Expert Ratings for Nektar Therapeutics
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 11, 2024
Via
Benzinga
Biotech's Lawsuit With Eli Lilly Might Catalyze Stock
March 29, 2024
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 04, 2024
Via
Benzinga
Nektar Therapeutics: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Earnings Scheduled For March 4, 2024
March 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 12, 2024
Via
Benzinga
The One-Minute Market Report - Saturday, Aug. 12
August 12, 2023
Via
Talk Markets
Topics
ETFs
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 07, 2023
Via
Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 07, 2023
Via
Benzinga
Why Is Nektar Therapeutics Stock Surging Today?
August 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via
Benzinga
Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday
May 10, 2023
Via
Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
April 18, 2023
Via
Benzinga
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.